Fig. 6From: MiR-613 inhibits the proliferation, migration, and invasion of papillary thyroid carcinoma cells by directly targeting TAGLN2Inhibition of EMT by miR-613 via the direct targeting of TAGLN2 in papillary thyroid cancer (PTC) cells. K1, TPC-1, and BCPAP cells were transfected with miR-613 mimics or mimics + TAGLN2. a Decreased E-cadherin expression level and increased N-cadherin, Vimentin, and MMP2 expression levels in mimics group compared with the mimics + TAGLN2 group. b Relative expression levels of EMT-related markers. * p < 0.05, **p < 0.01, *** p < 0.001, **** p < 0.0001Back to article page